{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:43:09Z","timestamp":1777956189829,"version":"3.51.4"},"reference-count":25,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,25]]},"DOI":"10.18632\/oncotarget.18388","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T12:30:38Z","timestamp":1496838638000},"page":"50015-50022","source":"Crossref","is-referenced-by-count":23,"title":["The effect of CA125 on metastasis of ovarian cancer: old marker new function"],"prefix":"10.18632","volume":"8","author":[{"given":"Qin","family":"Yuan","sequence":"first","affiliation":[{"name":"School of Laboratory Science, Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayin","family":"Song","sequence":"additional","affiliation":[{"name":"The Department of Clinical Laboratory, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Yang","sequence":"additional","affiliation":[{"name":"The Department of Laboratory Science, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Laboratory Science, Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyu","family":"Huo","sequence":"additional","affiliation":[{"name":"School of Laboratory Science, Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Laboratory Science, Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxu","family":"Yu","sequence":"additional","affiliation":[{"name":"The Department of Laboratory Science, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunde","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Laboratory Science, Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[{"name":"The Department of Laboratory Science, Tianjin Fourth Central Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijing","family":"Bao","sequence":"additional","affiliation":[{"name":"School of Laboratory Science, Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2217\/WHE.14.37","article-title":"Ovarian cancer: diagnostic, biological and prognostic aspects","volume":"10","author":"Trop\u00e9","year":"2014","journal-title":"Womens Health (Lond)"},{"key":"2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.envpol.2015.05.024","article-title":"Ovarian cancer mortality and industrial pollution","volume":"205","author":"Fernandez-Navarro","year":"2015","journal-title":"Environ Pollut"},{"key":"3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6874-13-8","article-title":"Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer","volume":"13","author":"Stokes-Lampard","year":"2013","journal-title":"BMC Womens Health"},{"key":"4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2014.09.005","article-title":"Ca125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy","volume":"135","author":"Rouzier","year":"2014","journal-title":"Gynecol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"e88334","DOI":"10.1371\/journal.pone.0088334","article-title":"Polymorphisms of Muc16 (Ca125) and Muc1 (Ca15.3) in relation to ovarian cancer risk and survival","volume":"9","author":"Cramer","year":"2014","journal-title":"PLoS One"},{"key":"6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.18632\/oncotarget.9191","article-title":"C-terminus of MUC16 activates Wnt signaling pathway through its interaction with \u03b2-catenin to promotetumorigenesis and metastasis","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1038\/srep09759","article-title":"Membrane proximal ectodomain cleavage of Muc16 occurs in the acidifying golgi\/post-golgi compartments","volume":"5","author":"Batra","year":"2015","journal-title":"Sci Rep"},{"key":"8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-13-129","article-title":"MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","volume":"13","author":"Patankar","year":"2014","journal-title":"Mol Cancer"},{"key":"9","first-page":"152","article-title":"Meigs' syndrome with elevated Ca-125 and He-4: a case of luteinized fibrothecoma","volume":"14","author":"Kotarski","year":"2015","journal-title":"Prz Menopauzalny"},{"key":"10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13048-016-0247-6","article-title":"High Levels of pretreatment Ca125 are associated to improved survival in high grade serous ovarian carcinoma","volume":"9","author":"Mendez","year":"2016","journal-title":"J Ovarian Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.7150\/jca.14615","article-title":"Clinical efficacy of ovarian cancer screening","volume":"7","author":"Konishi","year":"2016","journal-title":"J Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/10799893.2015.1080273","article-title":"The microrna regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases","volume":"36","author":"John","year":"2016","journal-title":"J Recept Signal Transduct Res"},{"key":"13","first-page":"1413","article-title":"transforming growth factor-beta-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis","volume":"38","author":"Kania","year":"2016","journal-title":"Eur Heart J"},{"key":"14","first-page":"219","article-title":"Muc16 mucin (Ca125) regulates the formation of multicellular aggregates by altering B-catenin signaling","volume":"5","author":"Pich\u00e9","year":"2015","journal-title":"Am J Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.7314\/APJCP.2016.17.4.1881","article-title":"Impact of preoperative serum levels of CA 125 on epithelial ovarian cancer survival","volume":"17","author":"Pradjatmo","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2010.07.025","article-title":"Ca125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study","volume":"119","author":"de Hullu","year":"2010","journal-title":"Gynecol Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1757-2215-3-22","article-title":"Longitudinal monitoring of Ca125 levels provides additional information about survival in ovarian cancer","volume":"3","author":"Braun","year":"2010","journal-title":"J Ovarian Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2015.09.006","article-title":"F14512, a polyamine-vectorized inhibitor of topoisomerase ii, exhibits a marked anti-tumor activity in ovarian cancer","volume":"370","author":"Annereau","year":"2016","journal-title":"Cancer Lett"},{"key":"19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2015.09.015","article-title":"Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer","volume":"139","author":"Bristow","year":"2015","journal-title":"Gynecol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsbmb.2014.11.005","article-title":"suppression of epithelial ovarian cancer invasion into the omentum by 1alpha, 25-dihydroxyvitamin D3 and its receptor","volume":"148","author":"Bai","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"e2157","DOI":"10.1038\/cddis.2015.401","article-title":"Arhgap10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells","volume":"7","author":"Cheng","year":"2016","journal-title":"Cell Death Dis"},{"key":"22","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1007\/s13277-015-3638-1","article-title":"Analysis of Uhrf1 expression in human ovarian cancer tissues and its regulation in cancer cell growth","volume":"36","author":"Hu","year":"2015","journal-title":"Tumour Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12885-016-2516-6","article-title":"Silibinin induces mitochondrial Nox4-mediated endoplasmic reticulum stress response and its subsequent apoptosis","volume":"16","author":"Ahn","year":"2016","journal-title":"BMC Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.2147\/OTT.S105245","article-title":"The roles of serum Cxcl16 in circulating tregs and gastrointestinal stromal tumor cells","volume":"9","author":"Xu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"25","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/jcmm.12926","article-title":"The expression of lamin a mutant R321x leads to endoplasmic reticulum stress with aberrant Ca2+ handling","volume":"20","author":"Svelto","year":"2016","journal-title":"J Cell Mol Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T21:09:16Z","timestamp":1589144956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":25,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,7,25]]}},"alternative-id":["18388","28637006"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18388","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}